# Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy

> **NCT04808466** · PHASE2 · UNKNOWN · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 231 (estimated)

## Conditions studied

- Gastric Cancer
- Chemotherapy Effect
- Surgery
- Metastasis
- Survival

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Lobaplatin

## Key facts

- **NCT ID:** NCT04808466
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-18
- **Primary completion:** 2022-09-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 231 (ESTIMATED)
- **Last updated:** 2022-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04808466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04808466, "Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04808466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*